Cc1cc(C)n(C(=O)C(C)n2nc([N+](=O)[O-])c(Br)c2C)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?